|
Experimental approach | Effects | Reference |
|
TRPM2 KO hippocampal slice | Deficit in LTD, GSK3β inactivation | [39] |
TRPM2 KO glia and neuron culture | Glutathione homeostasis loss, inflammation |
[21, 48] |
TRPM2 KO animal stroke | Neuroprotection, GSK3β inhibition | [54] |
Expression of TRPM2 in striatal culture, Aβ/oxidative stress | Cell death | [52] |
Human microglia culture, rat brain ischemia, inflammation/oxidative stress/electrophysiology | TRPM2 activated in microglia by ADPR | [24] |
TRPM2 KO, ROS and inflammation in whole animal | Negative feedback |
[19] |
Neuropathic and inflammatory pain in TRPM2 KO animal | Inhibition of microglia and pain in KO mice |
[17, 22] |
Expression of TRPM2 in human glioblastoma, oxidative stress | Promoting cell death | [55] |
Electrophysiology in microglia, ADPR/H2O2 | Induction of Ca2+ influx and TRPM2 current |
[26, 56] |
Diabetic rat, brain and DRG | TRPM2 activity and oxidative stress enhanced | [50] |
Pharmacological gene deletion of TRPM2 in microglia | TRPM2 mediates inflammation through p38MAPK/JNK | [28] |
TRPM2/APP/PS1 KO mice | Absent microglia activation and memory impairment | [20] |
|